Avendus Capital Advises Slayback Pharma LLC on Its Fundraise
Princeton, New Jersey based Slayback Pharma LLC (“Slayback”) announced that it has entered into an agreement with The Everstone Group (“Everstone”) to invest up to USD 50 million in primary funding. Slayback, founded by Ajay Singh and backed by KKR, has created has a strong portfolio of complex generics and specialty pharmaceuticals products. In 2019, Slayback received approvals for three products. The funds will be used for expansion of the injectable and alternate dosage forms led product portfolio.
Avendus Capital is the exclusive financial advisor to Slayback on this transaction.
Slayback Pharma LLC
Post the transaction, Everstone will join KKR as investor on the board of Slayback.
REACH OUT
Get in touch with us
We believe in audacious goals and we are here to partner with you, every step of the way.
Explore how we can help your business scale
